Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Latest
Popular

Chemo-radiotherapy for bladder cancer

Prof Nick James - University of Birmingham, UK
Chemo-radiotherapy for bladder cancer ( Prof Nick James - University of Birmingham, UK )
25 Feb 2013

Effect of therapeutic anticoagulation on overall survival in men receiving docetaxel for mCRPC

Dr Caroline Pratz - Kimmel Cancer Center, Johns Hopkins University, Baltimore
Effect of therapeutic anticoagulation on overall survival in men receiving docetaxel for mCRPC ( Dr Caroline Pratz - Kimmel Cancer Center, Johns Hopkins University, Baltimore )
25 Feb 2013

Expert overview of hot news in lymphoma from ASH 2012 (2/2)

Prof John Gribben, Prof Myron Czuczman, Prof Wolfram Brugger
Expert overview of hot news in lymphoma from ASH 2012 (2/2) ( Prof John Gribben, Prof Myron Czuczman, Prof Wolfram Brugger )
20 Dec 2012

Multiple myeloma advances for the future suggested by phase I clinical research

Dr Jesus Berdeja - Sarah Cannon Research Institute, Nashville, USA
Multiple myeloma advances for the future suggested by phase I clinical research ( Dr Jesus Berdeja - Sarah Cannon Research Institute, Nashville, USA )
20 Dec 2012

Neurocognitive impact in adjuvant chemotherapy for breast cancer

Prof Bernadine Cimprich - University of Michigan School of Nursing, Ann Arbor, USA
Neurocognitive impact in adjuvant chemotherapy for breast cancer ( Prof Bernadine Cimprich - University of Michigan School of Nursing, Ann Arbor, USA )
17 Dec 2012

Eribulin fails to demonstrate superiority over capecitabine in advanced breast cancer

Dr Peter Kaufman – Norris-Cotton Cancer Center, Lebanon, USA
Eribulin fails to demonstrate superiority over capecitabine in advanced breast cancer ( Dr Peter Kaufman – Norris-Cotton Cancer Center, Lebanon, USA )
16 Dec 2012

Results of the TACT2 and BEATRICE breast cancer trials

Prof David Cameron – Edinburgh University, UK
Results of the TACT2 and BEATRICE breast cancer trials ( Prof David Cameron – Edinburgh University, UK )
16 Dec 2012

Diverse genetic alterations found in triple-negative breast cancers after neoadjuvant chemo

Dr Justin Balko – Vanderbilt-Ingram Cancer Center, Nashville, USA
Diverse genetic alterations found in triple-negative breast cancers after neoadjuvant chemo ( Dr Justin Balko – Vanderbilt-Ingram Cancer Center, Nashville, USA )
16 Dec 2012

HDAC inhibition sensitises triple-negative breast cancer cells to PARP inhibition

Dr Kapil Bhalla - University of Kansas Cancer Center, Kansas City, USA
HDAC inhibition sensitises triple-negative breast cancer cells to PARP inhibition ( Dr Kapil Bhalla - University of Kansas Cancer Center, Kansas City, USA )
13 Dec 2012

The BTK inhibitor ibrutinib (PCI-32765) in combination with rituximab

Prof Jan Burger - The University of Texas MD Anderson Cancer Center, Houston, USA
The BTK inhibitor ibrutinib (PCI-32765) in combination with rituximab ( Prof Jan Burger - The University of Texas MD Anderson Cancer Center, Houston, USA )
13 Dec 2012

Neratinib shows beneficial effects in the treatment of HER2 mutated breast cancer

Prof Ron Bose – Washington University School of Medicine, St. Louis, USA
Neratinib shows beneficial effects in the treatment of HER2 mutated breast cancer ( Prof Ron Bose – Washington University School of Medicine, St. Louis, USA )
12 Dec 2012

Adjuvant chemotherapy for locally recurrent breast cancer

Dr Stefan Aebi – Luzerner Kantonsspital, Switzerland
Adjuvant chemotherapy for locally recurrent breast cancer ( Dr Stefan Aebi – Luzerner Kantonsspital, Switzerland )
12 Dec 2012

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation